1
/
of
1
Elabscience
SKU:PKSV030413
Recombinant SARS-CoV-2 Spike RBD(Y508H)(His Tag)
Recombinant SARS-CoV-2 Spike RBD(Y508H)(His Tag)
Regular price
$1,105.00 USD
Regular price
Sale price
$1,105.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Introducing the Recombinant SARS-CoV-2 Spike RBD(Y508H)(His Tag), a cutting-edge product designed to facilitate advanced research and development in the field of virology. This meticulously engineered recombinant protein offers a highly purified and reliable solution for studying the Spike Receptor Binding Domain (RBD) of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Crafted with utmost precision, the Recombinant SARS-CoV-2 Spike RBD(Y508H)(His Tag) showcases an innovative Y508H mutation, enabling enhanced binding affinity to the host receptor. This strategic modification empowers researchers to delve deeper into the intricate mechanisms of viral entry and host-pathogen interactions, ultimately contributing to the development of effective therapeutic interventions.
With its His Tag, this recombinant protein ensures facile purification and efficient detection, streamlining experimental workflows and enabling accurate quantification. Its exceptional purity and stability guarantee consistent and reproducible results, instilling confidence in scientific investigations.
The Recombinant SARS-CoV-2 Spike RBD(Y508H)(His Tag) is meticulously produced using state-of-the-art recombinant DNA technology, adhering to stringent quality control measures. Each batch undergoes rigorous testing to ensure conformity to the highest industry standards, guaranteeing optimal performance and reliability.
This product is intended for research purposes only and is not suitable for diagnostic or therapeutic applications. It is supplied in a lyophilized form, preserving its integrity and extending its shelf life. Detailed instructions for reconstitution and storage are provided, ensuring ease of use and long-term viability.
In summary, the Recombinant SARS-CoV-2 Spike RBD(Y508H)(His Tag) represents a breakthrough tool for scientists and researchers seeking to unravel the complexities of SARS-CoV-2 infection. Its exceptional quality, stability, and enhanced binding affinity make it an indispensable asset in the pursuit of novel therapeutic strategies and the advancement of our understanding of this global health crisis.
Crafted with utmost precision, the Recombinant SARS-CoV-2 Spike RBD(Y508H)(His Tag) showcases an innovative Y508H mutation, enabling enhanced binding affinity to the host receptor. This strategic modification empowers researchers to delve deeper into the intricate mechanisms of viral entry and host-pathogen interactions, ultimately contributing to the development of effective therapeutic interventions.
With its His Tag, this recombinant protein ensures facile purification and efficient detection, streamlining experimental workflows and enabling accurate quantification. Its exceptional purity and stability guarantee consistent and reproducible results, instilling confidence in scientific investigations.
The Recombinant SARS-CoV-2 Spike RBD(Y508H)(His Tag) is meticulously produced using state-of-the-art recombinant DNA technology, adhering to stringent quality control measures. Each batch undergoes rigorous testing to ensure conformity to the highest industry standards, guaranteeing optimal performance and reliability.
This product is intended for research purposes only and is not suitable for diagnostic or therapeutic applications. It is supplied in a lyophilized form, preserving its integrity and extending its shelf life. Detailed instructions for reconstitution and storage are provided, ensuring ease of use and long-term viability.
In summary, the Recombinant SARS-CoV-2 Spike RBD(Y508H)(His Tag) represents a breakthrough tool for scientists and researchers seeking to unravel the complexities of SARS-CoV-2 infection. Its exceptional quality, stability, and enhanced binding affinity make it an indispensable asset in the pursuit of novel therapeutic strategies and the advancement of our understanding of this global health crisis.
Share
